Cellectis S.A. ADR (CLLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 49,217 | 9,193 | 25,725 | 38,597 | 82,456 |
| Cost of Goods | N/A | 737 | 1,772 | 1,844 | 36,275 |
| Gross Profit | 49,217 | 8,456 | 23,953 | 36,753 | 46,181 |
| Operating Expenses | 108,772 | 106,495 | 114,390 | 141,078 | 131,893 |
| Operating Income | -59,554 | -97,302 | -89,666 | -103,481 | -85,437 |
| Interest Expense | 21,614 | 40,642 | 17,815 | 6,486 | 17,514 |
| Other Income | 44,407 | 21,479 | 8,880 | 13,218 | 5,468 |
| Pre-tax Income | -36,761 | -116,465 | -98,601 | -96,749 | -97,483 |
| Income Tax | N/A | 371 | 87 | N/A | N/A |
| Net Income Continuous | -36,761 | -116,835 | -98,688 | -96,749 | -97,483 |
| Net Income Discontinuous | N/A | 8,392 | -15,345 | -28,358 | N/A |
| Minority Interests | N/A | -7,384 | -7,894 | -10,910 | -16,409 |
| Net Income | $-36,761 | $-101,059 | $-106,140 | $-114,197 | $-81,074 |
| EPS Basic Total Ops | -0.41 | -1.77 | -2.33 | -2.55 | -1.91 |
| EPS Basic Continuous Ops | -0.41 | -2.05 | -2.17 | -2.16 | -2.29 |
| EPS Basic Discontinuous Ops | N/A | 0.15 | -0.34 | -0.63 | N/A |
| EPS Diluted Total Ops | -0.41 | -1.77 | -2.33 | -2.55 | -1.91 |
| EPS Diluted Continuous Ops | -0.41 | -2.05 | -2.17 | -2.16 | -2.29 |
| EPS Diluted Discontinuous Ops | N/A | 0.15 | -0.34 | -0.63 | N/A |
| EPS Diluted Before Non-Recurring Items | -0.41 | -2.05 | -2.17 | -2.55 | -1.91 |
| EBITDA(a) | $-39,709 | $-78,779 | $-71,230 | $-89,325 | $-75,618 |